imATLAS · Multimodal imaging of lung tissue based on LIBS, MALDI and histology fusion to unravel sarcoidosis causes
Horizon Europe — Marie Skłodowska-Curie Actions
- Duration
- 2023-10-01 → 2025-09-30
- EU contribution
- €196,751
- Participants
- 1
- Scheme
- HORIZON-TMA-MSCA-PF-EF
Lines connect the coordinator with its partners.
Results in brief
Multimodal imaging of lung tissue based on LIBS, MALDI and histology fusion to unravel sarcoidosis causes
The imATLAS project's main objective was to develop and validate a novel multimodal imaging workflow by fusing two powerful analytical techniques: Laser-Induced Breakdown Spectroscopy (LIBS) for elemental mapping (e.g., metals) and Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry (MALDI-MSI) for molecular mapping (e.g., lipids, peptides). The ultimate goal was to co-localize these elemental and molecular signals in human lung tissue to identify specific "fingerprints" of exposure and unravel the causes of idiopathic diseases, particularly those triggered by an exogenous agent. Identifying the specific triggering agent is critical for the diagnosis and treatment of these diseases, yet effective diagnostic tools to do this are lacking. The imATLAS project has pushed the state-of-the-art in two key areas. First, the dual-detection kHz-LIBS prototype represents a significant hardware innovation for elemental bio-imaging, solving a key limitation of standard systems. Second, the "feature-level" LIBS-MALDI fusion workflow provides a viable new method for correlating elemental and molecular data in complex tissues. The existing kHz-LIBS system was substantially re-engineered for biological analysis. A new optical microscopy path was integrated for precise focusing on transparent tissue. Most critically, a novel dual-detection (ICCD/CMOS) system was designed and implemented, allowing the system to simultaneously detect trace-level elements (like particles) and high-concentration matrix elements. The new instrument achieved a 10 µm spatial resolution—a 2x improvement on the original goal—and successfully detected metallic nanoparticles in the rodent lung models. Data processing became the project's principal focus. When a simple "low-level" fusion failed, a successful "mid-level" (or "feature-level") fusion strategy was developed. This workflow statistically correlates 2D elemental maps (from LIBS) with thousands of molecular spectra (from MALDI) to find significant co-localized signals. This work, which included the first-time application of PCA for LIBS denoising in this context, led to two peer-reviewed publications. A key result from the imATLAS project was the successful alignment and correlation of elemental LIBS images with various molecular MALDI-MSI images from a rodent tissue model, which validated this new workflow.
Data: CORDIS, © European Union
Project objective
Sarcoidosis is an inflammatory, granulomatous disorder with unknown cause highly associated with occupational exposures. It has geographically variable prevalence, with an elevated cost for the patients. It can be detected among metal-exposed workers, firefighters, rock, glass wool or agriculture workers. The most prominent example being rescuers in the World Trade Center in 2001. The need for accurate information about the exposures and causes of sarcoidosis is a limiting factor for clinicians, therefore, supplying them with relevant information will improve the patient's healthcare trajectory.The aim of imATLAS project (IMaging Analysis of Tissues via LAser Spectrometry) is to develop a novel multi-analytical procedure based on LIBS and MALDI-MSI, in combination with standard histology, to identify, localize and relate exogenous and endogenous agents allowing to elucidate possible external causes and biomarkers of sarcoidosis. A data analysis pipeline will be created containing all the bio-statistical steps, graphical representation, exposure and biomarker search approaches, as well as the image fusion results, to provide a global view with elemental and molecular information of the tissue, in addition to the pathologic information provided by histology. The scripts will be publicly accessible, available to other researchers as well as widely adaptable to different imaging techniques and instruments. Furthermore, the results obtained will be released as an easy-to-read file (Quicklook) to present all the useful multimodal analytical information to clinicians and optimize the diagnosis and treatment of patients.
Original text from CORDIS.
Participants
- UNIVERSITE LYON 1 CLAUDE BERNARD · Villeurbanne CedexCoordinatorFrance
Links
- View on CORDIS
- DOI: 10.3030/101106090
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e50b736f99&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e521de69e6&appId=PPGMS
Data: CORDIS, © European Union
